Cargando…

Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis

BACKGROUND: Patients with advanced malignancies, e.g. lung cancer, ovarian cancer or melanoma, frequently present with brain metastases. Clinical presentation and disease progression of cancer is in part shaped by the interaction of the immune system with malignant cells. Antigen-targeted immune res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhenjiang, Liu, Rao, Martin, Luo, Xiaohua, Sandberg, Elisabeth, Bartek, Jiri, Schoutrop, Esther, von Landenberg, Anna, Meng, Qingda, Valentini, Davide, Poiret, Thomas, Sinclair, Georges, Peredo, Inti-Harvey, Dodoo, Ernest, Maeurer, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605370/ https://www.ncbi.nlm.nih.gov/pubmed/28888924 http://dx.doi.org/10.1016/j.ebiom.2017.08.024

Ejemplares similares

Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma
por: Liu, Zhenjiang, et al.
Publicado: (2017)

Epstein–Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer
por: Liu, Zhenjiang, et al.
Publicado: (2018)

Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma
por: Valentini, Davide, et al.
Publicado: (2018)

Correction: Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma
por: Valentini, Davide, et al.
Publicado: (2018)

Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme
por: Zhenjiang, Liu, et al.
Publicado: (2018)

NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma
por: Liu, Zhenjiang, et al.
Publicado: (2017)

Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-reactive T-cell responses
por: Meng, Qingda, et al.
Publicado: (2018)

A fast assay to gauge for TAA-reactive T cells in PBMCS from patients with pancreatic cancer
por: Rangelova, Elena B, et al.
Publicado: (2014)

Generation of tumor-infiltrating lymphocytes from pancreatic cancer lesions for cellular therapy
por: Meng, Qingda, et al.
Publicado: (2014)

Rapid expansion of TILs from patients with glioma and recognition of autologous tumor
por: Zhenjiang, Liu, et al.
Publicado: (2014)

Expression of TAAs in glioblastoma and expansion of anti-TAA -reactive T cells
por: Dodoo, Ernest, et al.
Publicado: (2014)

CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors
por: Meng, Qingda, et al.
Publicado: (2018)

IL-2, IL-15 and IL-21 expand T cells for targeted adoptive therapy
por: Liu, Zhenjiang, et al.
Publicado: (2015)

Enhanced tumor-infiltrating lymphocytes (eTIL) for cellular therapy of patients with pancreatic cancer or glioblastoma
por: Meng, Qingda, et al.
Publicado: (2015)

T-Cell Therapy: Options for Infectious Diseases
por: Parida, Shreemanta K., et al.
Publicado: (2015)

B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis
por: Rao, Martin, et al.
Publicado: (2015)

Adaptive hypofractionated gamma knife radiosurgery for a large brainstem metastasis
por: Sinclair, Georges, et al.
Publicado: (2016)

KRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic Cancer
por: Meng, Qingda, et al.
Publicado: (2018)

Neoepitope targets of tumour-infiltrating lymphocytes from patients with pancreatic cancer
por: Meng, Qingda, et al.
Publicado: (2018)

The concept of rapid rescue radiosurgery in the acute management of critically located brain metastases: A retrospective short-term outcome analysis
por: Sinclair, Georges, et al.
Publicado: (2018)

Adaptive hypofractionated gamma knife radiosurgery in the acute management of brainstem metastases
por: Sinclair, Georges, et al.
Publicado: (2019)

Immunometabolism and Pulmonary Infections: Implications for Protective Immune Responses and Host-Directed Therapies
por: Rao, Martin, et al.
Publicado: (2019)

Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
por: Zumla, Alimuddin, et al.
Publicado: (2016)

Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: Impact of CMV infection and leukemia relapse
por: Luo, Xiao-Hua, et al.
Publicado: (2023)

Corrigendum: Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: impact of CMV infection and leukemia relapse
por: Luo, Xiao-Hua, et al.
Publicado: (2023)

Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation
por: Poiret, Thomas, et al.
Publicado: (2018)

Salvage gamma knife radiosurgery in the management of dysembryoplastic neuroepithelial tumors: Long-term outcome in a single-institution case series
por: Sinclair, Georges, et al.
Publicado: (2017)

Higher Human Cytomegalovirus (HCMV) Specific IgG Antibody Levels in Plasma Samples from Patients with Metastatic Brain Tumors Are Associated with Longer Survival
por: Peredo-Harvey, Inti, et al.
Publicado: (2023)

Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors
por: Einama, Takahiro, et al.
Publicado: (2017)

Targeting mesothelin in ovarian cancer
por: Ghafoor, Azam, et al.
Publicado: (2018)

Trogocytosis and fratricide killing impede MSLN-directed CAR T cell functionality
por: Schoutrop, Esther, et al.
Publicado: (2022)

Liver myofibroblasts of murine origins express mesothelin: Identification of novel rat mesothelin splice variants*
por: Fausther, Michel, et al.
Publicado: (2017)

Mesothelin-targeted second generation CAR-T cells inhibit growth of mesothelin-expressing tumors in vivo
por: Ye, Lin, et al.
Publicado: (2019)

Highly active CAR T cells that bind to a juxtamembrane region of mesothelin and are not blocked by shed mesothelin
por: Liu, Xiufen, et al.
Publicado: (2022)

An engineered T-cell engager with selectivity for high mesothelin-expressing cells and activity in the presence of soluble mesothelin
por: Snell, Daniel, et al.
Publicado: (2023)

Whole CMV Proteome Pattern Recognition Analysis after HSCT Identifies Unique Epitope Targets Associated with the CMV Status
por: Pérez-Bercoff, Lena, et al.
Publicado: (2014)

The role of radiosurgery in the acute management of fourth ventricle compression due to brain metastases
por: Sinclair, G., et al.
Publicado: (2018)

Tuned activation of MSLN-CAR T cells induces superior antitumor responses in ovarian cancer models
por: Schoutrop, Esther, et al.
Publicado: (2023)

The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors
por: Yu, Yi, et al.
Publicado: (2011)

Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironment
por: Zhang, Xianyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eei1ri7pg6j54gbbrpcvgct4nm